Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares Issued
Ratios

Pediatrix Medical (MD) Accumulated Depreciation & Amortization (2016 - 2025)

Pediatrix Medical (MD) has disclosed Accumulated Depreciation & Amortization for 15 consecutive years, with $126.5 million as the latest value for Q4 2024.

  • On a quarterly basis, Accumulated Depreciation & Amortization fell 11.36% to $126.5 million in Q4 2024 year-over-year; TTM through Dec 2024 was $126.5 million, a 11.36% decrease, with the full-year FY2024 number at $126.5 million, down 11.36% from a year prior.
  • Accumulated Depreciation & Amortization was $126.5 million for Q4 2024 at Pediatrix Medical, down from $142.7 million in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $172.2 million in Q4 2022 to a low of $6.8 million in Q2 2020.
  • A 5-year average of $81.9 million and a median of $77.5 million in 2020 define the central range for Accumulated Depreciation & Amortization.
  • Peak YoY movement for Accumulated Depreciation & Amortization: surged 479.05% in 2021, then decreased 17.13% in 2023.
  • Pediatrix Medical's Accumulated Depreciation & Amortization stood at $28.4 million in 2020, then soared by 479.05% to $164.7 million in 2021, then rose by 4.57% to $172.2 million in 2022, then decreased by 17.13% to $142.7 million in 2023, then decreased by 11.36% to $126.5 million in 2024.
  • Per Business Quant, the three most recent readings for MD's Accumulated Depreciation & Amortization are $126.5 million (Q4 2024), $142.7 million (Q4 2023), and $172.2 million (Q4 2022).